cui1,cui2,relation,name1,name2,type1,type2,weight,predicate
C0013216,C1696114,NEG_AFFECTS,Pharmacotherapy,Stubbornness,topp,mobd,2,NEG_AFFECTS_TOPPnafctMOBD
C0079613,C0042693,NEG_AFFECTS,Adoptive Immunotherapy,Violence,topp,mobd,1,NEG_AFFECTS_TOPPnafctMOBD
C0083089,C0522174,NEG_AFFECTS,IVA protocol,Delinquent behavior,topp,mobd,1,NEG_AFFECTS_TOPPnafctMOBD
C0083355,C0003467,NEG_AFFECTS,amsacrine/azacitidine/etoposide,Anxiety,topp,mobd,1,NEG_AFFECTS_TOPPnafctMOBD
C0204727,C0003467,NEG_AFFECTS,Isolation procedure,Anxiety,topp,mobd,1,NEG_AFFECTS_TOPPnafctMOBD
C0441516,C0233494,NEG_AFFECTS,Demand (clinical),Tension,topp,mobd,1,NEG_AFFECTS_TOPPnafctMOBD
